Specifically, lower levels of albumin (OR, 0.453; 95% CI, 0.410–0.500; P < 0.001), GGT (OR, 0.941; 95% CI, 0.919–0.964; P < 0.001), and TBIL (OR, 0.928; 0.877–0.982; P = 0.009), along with higher levels of the urea nitrogen-to-creatinine ratio (OR, 1.461; 95% CI, 1.352–1.579; P < 0.001), were recognized as independent predictors of disease risk for MS (Table 3). The gene discussed is ALB; the disease is myeloid sarcoma.